about
AZD1305 exerts atrial predominant electrophysiological actions and is effective in suppressing atrial fibrillation and preventing its reinduction in the dogDronedarone-current status in management of atrial fibrillationA network-oriented perspective on cardiac calcium signalingPharmacological management of atrial fibrillation: one, none, one hundred thousand.Ion channel trafficking: a new therapeutic horizon for atrial fibrillationAdvances in the Pharmacological Treatment of Atrial Fibrillation.Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation.Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue.Rotor termination is critically dependent on kinetic properties of I kur inhibitors in an in silico model of chronic atrial fibrillation.Identification of absorbed constituents and metabolites in rat plasma after oral administration of Shen-Song-Yang-Xin using ultra-performance liquid chromatography combined with quadrupole time-of-flight mass spectrometry.Matrine inhibits pacing induced atrial fibrillation by modulating I(KM3) and I(Ca-L).Protein kinase C as a stress sensor.Atrial-selective prolongation of refractory period with AVE0118 is due principally to inhibition of sodium channel activity.The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysisIntracellular lactate signaling cascade in atrial remodeling of mitral valvular patients with atrial fibrillation.Pharmacological modulation of gap junction function with the novel compound rotigaptide: a promising new principle for prevention of arrhythmias.Enhancement of ventricular gap-junction coupling by rotigaptide.TASK-1 channels may modulate action potential duration of human atrial cardiomyocytesAtrial-selective effects of chronic amiodarone in the management of atrial fibrillation.Atrial-selective sodium channel blockers: do they exist?S3b amino acid substitutions and ancillary subunits alter the affinity of Heteropoda venatoria toxin 2 for Kv4.3.Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis.Atrial-selective sodium channel block for the treatment of atrial fibrillation.New pharmacological strategies for the treatment of atrial fibrillationAtrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.Pulmonary vein isolation for the treatment of atrial fibrillation: past, present and future.New developments in atrial antiarrhythmic drug therapy.Discovery of N-(3,5-bis(1-pyrrolidylmethyl)-4-hydroxybenzyl)-4-methoxybenzenesulfamide (sulcardine) as a novel anti-arrhythmic agent.Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides.Strategic approaches to optimizing peptide ADME propertiesVentricular anti-arrhythmic effects of heptanol in hypokalaemic, Langendorff-perfused mouse heartsHow Do Atrial-Selective Drugs Differ From Antiarrhythmic Drugs Currently Used in the Treatment of Atrial Fibrillation?High-content screening of drug-induced cardiotoxicity using quantitative single cell imaging cytometry on microfluidic device.The importance of being profiled: improving drug candidate safety and efficacy using ion channel profiling.Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation.Antiarrhythmic drug-induced internalization of the atrial-specific k+ channel kv1.5.Computational Models for Predictive Cardiac Ion Channel Pharmacology.Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.Calcium leaks: initiator of atrial fibrillation?[Basic mechanisms of the new antiarrhythmic drugs in atrial fibrillation].
P2860
Q24607775-4C6D3BC1-E23C-4CA4-AC70-2CB667FAC004Q27001666-6132C4EB-D196-4C1A-B69F-A39093ACA693Q27023389-55E138D6-0A92-415B-9B7C-BBFD86E8FDE0Q33902193-C8AEC4E3-F8EC-40F7-ACE1-1CE7793A5CD5Q34101658-AFEE2008-762A-47F0-99B9-33F63370E76AQ34383573-23D0B5E6-920E-432D-A8AF-A4C00411DB5FQ34502114-71A6DAA8-4C39-4644-9BAB-4706E8D2281AQ34752070-6D0C2F3B-0370-479F-AA16-7E08D2410108Q35077954-F608EC40-F60A-4397-B16A-1E9A384622F8Q35566399-1ED1E8EF-16BF-4E09-A2A2-DDB5A372A796Q35641994-B77FEB93-B749-4D54-ABC9-04C9AD99D7F8Q36003170-1819A9AA-AB49-4848-B745-C77AD47A92A1Q36013079-566D21BA-1EFB-4220-8AB8-28C05EF43C29Q36650575-68C4208A-0637-4A58-AF29-776FBAE48B6DQ36690912-2C76A600-686F-4E69-A44C-896D67C0A79AQ36936412-8FBF05F3-6B2D-4B3C-B340-7CFD53E80D8AQ36952968-551A0791-1A04-402D-BCF1-AF9FAF7A9756Q37005224-C49DA9C9-E2B3-4BCC-8A37-9B3F25D6C456Q37093085-ABED1BC4-86E6-477C-BC2D-EC727EA04CFDQ37231700-ECD43863-415B-4C55-AAF3-FBD85E6B9DEDQ37240251-4204A351-7B11-418C-9D7E-CB30F8CAE858Q37282970-9E1A4795-A63D-416A-8236-75C8B80A2D8AQ37494653-C0883DD2-8F1B-42BE-A4CB-88C2E7458233Q37554693-A4C286DE-16A8-42AB-85E0-DF8B1F658B9CQ37584282-FA118CBF-A95C-49E7-88C7-A3C346B44CB4Q37656335-0009EB15-965E-466B-812C-9CE0042C10E4Q37697498-A30885D6-B851-49B6-B97C-6A61F8B817D4Q37729469-EFA7B3DB-AB6F-47C0-A2B1-EA979994F289Q38110433-6BCF4372-8909-4CCA-8A67-7039EEC75916Q38264736-0E5D217B-04DD-4379-B9D4-629D22C48734Q38719030-12469868-70EC-4BFC-9524-BE09C3805141Q38790685-0456EBC4-42EE-4041-8D63-152D0A0ED862Q39634258-0F99BB41-8A73-46E4-8FDC-D7F619FCA277Q39749838-E821E7C7-7894-4326-B661-AC9E14938DEFQ39760319-2CB47B93-9C46-4A8A-B3E2-1D5221FCE3C5Q39851183-1A5D68F4-DD58-4822-8EA6-B8EBE5D81A9DQ40243231-3F7CD529-C152-4CA4-9C4B-E9FE74135C98Q40426127-B9807F31-BB32-4A72-815C-569BB83C5181Q40743073-3CBB301B-190E-453F-9F2F-78FC19C8C541Q41560451-1FDF864E-6C00-4A44-810D-58BAD44B78E1
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Innovative approaches to anti-arrhythmic drug therapy.
@ast
Innovative approaches to anti-arrhythmic drug therapy.
@en
type
label
Innovative approaches to anti-arrhythmic drug therapy.
@ast
Innovative approaches to anti-arrhythmic drug therapy.
@en
prefLabel
Innovative approaches to anti-arrhythmic drug therapy.
@ast
Innovative approaches to anti-arrhythmic drug therapy.
@en
P2860
P356
P1476
Innovative approaches to anti-arrhythmic drug therapy
@en
P2093
Leif Carlsson
P2860
P2888
P304
P356
10.1038/NRD2112
P577
2006-12-01T00:00:00Z